Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Mucosal Immunol ; 13(3): 518-529, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-31900406

RESUMO

Priming at the site of natural infection typically elicits a protective T cell response against subsequent pathogen encounter. Here, we report the identification of a novel fungal antigen that we harnessed for mucosal vaccination and tetramer generation to test whether we can elicit protective, antigen-specific tissue-resident memory (Trm) CD4+ T cells in the lung parenchyma. In contrast to expectations, CD69+, CXCR3+, CD103- Trm cells failed to protect against a lethal pulmonary fungal infection. Surprisingly, systemic vaccination induced a population of tetramer+ CD4+ T cells enriched within the pulmonary vasculature, and expressing CXCR3 and CX3CR1, that migrated to the lung tissue upon challenge and efficiently protected mice against infection. Mucosal vaccine priming of Trm may not reliably protect against mucosal pathogens.


Assuntos
Antígenos/imunologia , Movimento Celular/imunologia , Resistência à Doença/imunologia , Fungos/imunologia , Interações Hospedeiro-Patógeno/imunologia , Memória Imunológica , Micoses/imunologia , Animais , Biomarcadores , Epitopos de Linfócito T/imunologia , Imunização , Imunofenotipagem , Interferon gama , Camundongos , Micoses/microbiologia , Micoses/prevenção & controle , Receptores CXCR3/metabolismo , Mucosa Respiratória/imunologia , Mucosa Respiratória/metabolismo , Linfócitos T/imunologia , Linfócitos T/metabolismo , Vacinas/imunologia
2.
PLoS Pathog ; 13(8): e1006568, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28793349

RESUMO

The development of vaccines against fungi and other intracellular microbes is impeded in part by a lack of suitable adjuvants. While most current vaccines against infectious diseases preferentially induce production of antibodies, cellular immunity is essential for the resolution of fungal infections. Microbes such as fungi and Mycobacterium tuberculosis require Th17 and Th1 cells for resistance, and engage the C-type lectin receptors including Dectin-2. Herein, we discovered a novel Dectin-2 ligand, the glycoprotein Blastomyces Eng2 (Bl-Eng2). Bl-Eng2 triggers robust signaling in Dectin-2 reporter cells and induces IL-6 in human PBMC and BMDC from wild type but not Dectin-2-/- and Card9-/- mice. The addition of Bl-Eng2 to a pan-fungal subunit vaccine primed large numbers of Ag-specific Th17 and Th1 cells, augmented activation and killing of fungi by myeloid effector cells, and protected mice from lethal fungal challenge, revealing Bl-Eng2's potency as a vaccine adjuvant. Thus, ligation of Dectin-2 by Bl-Eng-2 could be harnessed as a novel adjuvant strategy to protect against infectious diseases requiring cellular immunity.


Assuntos
Adjuvantes Imunológicos/farmacologia , Proteínas Fúngicas/imunologia , Vacinas Fúngicas/imunologia , Lectinas Tipo C/imunologia , Adjuvantes Imunológicos/química , Animais , Blastomyces , Proteínas Fúngicas/química , Vacinas Fúngicas/química , Humanos , Lectinas Tipo C/metabolismo , Leucócitos Mononucleares/imunologia , Ligantes , Espectrometria de Massas , Camundongos , Camundongos Endogâmicos C57BL , Micoses/imunologia , Micoses/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA